Cargando…

Immune evasion and chronological decrease in titer of neutralizing antibody against SARS-CoV-2 and its variants of concerns in COVID-19 patients

Many variants of SARS-CoV-2 have emerged, and decreased neutralizing antibodies after vaccination and breakthrough infections have become a problem. The importance of monitoring titers of neutralizing antibodies is getting higher. We enrolled 146 COVID-19 patients, who were thought to be infected wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeshita, Masaru, Nishina, Naoshi, Moriyama, Saya, Takahashi, Yoshimasa, Ishii, Makoto, Saya, Hideyuki, Kondo, Yasushi, Kaneko, Yuko, Suzuki, Katsuya, Fukunaga, Koichi, Takeuchi, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988444/
https://www.ncbi.nlm.nih.gov/pubmed/35398519
http://dx.doi.org/10.1016/j.clim.2022.108999
_version_ 1784682962171723776
author Takeshita, Masaru
Nishina, Naoshi
Moriyama, Saya
Takahashi, Yoshimasa
Ishii, Makoto
Saya, Hideyuki
Kondo, Yasushi
Kaneko, Yuko
Suzuki, Katsuya
Fukunaga, Koichi
Takeuchi, Tsutomu
author_facet Takeshita, Masaru
Nishina, Naoshi
Moriyama, Saya
Takahashi, Yoshimasa
Ishii, Makoto
Saya, Hideyuki
Kondo, Yasushi
Kaneko, Yuko
Suzuki, Katsuya
Fukunaga, Koichi
Takeuchi, Tsutomu
author_sort Takeshita, Masaru
collection PubMed
description Many variants of SARS-CoV-2 have emerged, and decreased neutralizing antibodies after vaccination and breakthrough infections have become a problem. The importance of monitoring titers of neutralizing antibodies is getting higher. We enrolled 146 COVID-19 patients, who were thought to be infected with Wuhan-hu-1 or D614G strains, and examined the time course of neutralizing titers against six concerning strains (Wuhan-hu-1, Alpha, Beta, Gamma, Kappa, and Delta) using newly developed ELISA. The acquisition of neutralizing titer was positively associated with disease severity. Immune evasions were observed approximately 20 to 30% for Alpha, Kappa, and Delta variant, and 40 to 45% for Beta and Gamma variant. The titers against all strains decreased over time, and interestingly, while titers against Wuhan-hu-1 decreased by 23%, those to Delta variant decreased by 70%. Our simple, cost-effective, and non-hazardous system will be applicable to process numerous samples, such as monitoring titers against prevalent strains after infection or vaccination.
format Online
Article
Text
id pubmed-8988444
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Authors. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-89884442022-04-07 Immune evasion and chronological decrease in titer of neutralizing antibody against SARS-CoV-2 and its variants of concerns in COVID-19 patients Takeshita, Masaru Nishina, Naoshi Moriyama, Saya Takahashi, Yoshimasa Ishii, Makoto Saya, Hideyuki Kondo, Yasushi Kaneko, Yuko Suzuki, Katsuya Fukunaga, Koichi Takeuchi, Tsutomu Clin Immunol Article Many variants of SARS-CoV-2 have emerged, and decreased neutralizing antibodies after vaccination and breakthrough infections have become a problem. The importance of monitoring titers of neutralizing antibodies is getting higher. We enrolled 146 COVID-19 patients, who were thought to be infected with Wuhan-hu-1 or D614G strains, and examined the time course of neutralizing titers against six concerning strains (Wuhan-hu-1, Alpha, Beta, Gamma, Kappa, and Delta) using newly developed ELISA. The acquisition of neutralizing titer was positively associated with disease severity. Immune evasions were observed approximately 20 to 30% for Alpha, Kappa, and Delta variant, and 40 to 45% for Beta and Gamma variant. The titers against all strains decreased over time, and interestingly, while titers against Wuhan-hu-1 decreased by 23%, those to Delta variant decreased by 70%. Our simple, cost-effective, and non-hazardous system will be applicable to process numerous samples, such as monitoring titers against prevalent strains after infection or vaccination. The Authors. Published by Elsevier Inc. 2022-05 2022-04-07 /pmc/articles/PMC8988444/ /pubmed/35398519 http://dx.doi.org/10.1016/j.clim.2022.108999 Text en © 2022 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Takeshita, Masaru
Nishina, Naoshi
Moriyama, Saya
Takahashi, Yoshimasa
Ishii, Makoto
Saya, Hideyuki
Kondo, Yasushi
Kaneko, Yuko
Suzuki, Katsuya
Fukunaga, Koichi
Takeuchi, Tsutomu
Immune evasion and chronological decrease in titer of neutralizing antibody against SARS-CoV-2 and its variants of concerns in COVID-19 patients
title Immune evasion and chronological decrease in titer of neutralizing antibody against SARS-CoV-2 and its variants of concerns in COVID-19 patients
title_full Immune evasion and chronological decrease in titer of neutralizing antibody against SARS-CoV-2 and its variants of concerns in COVID-19 patients
title_fullStr Immune evasion and chronological decrease in titer of neutralizing antibody against SARS-CoV-2 and its variants of concerns in COVID-19 patients
title_full_unstemmed Immune evasion and chronological decrease in titer of neutralizing antibody against SARS-CoV-2 and its variants of concerns in COVID-19 patients
title_short Immune evasion and chronological decrease in titer of neutralizing antibody against SARS-CoV-2 and its variants of concerns in COVID-19 patients
title_sort immune evasion and chronological decrease in titer of neutralizing antibody against sars-cov-2 and its variants of concerns in covid-19 patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988444/
https://www.ncbi.nlm.nih.gov/pubmed/35398519
http://dx.doi.org/10.1016/j.clim.2022.108999
work_keys_str_mv AT takeshitamasaru immuneevasionandchronologicaldecreaseintiterofneutralizingantibodyagainstsarscov2anditsvariantsofconcernsincovid19patients
AT nishinanaoshi immuneevasionandchronologicaldecreaseintiterofneutralizingantibodyagainstsarscov2anditsvariantsofconcernsincovid19patients
AT moriyamasaya immuneevasionandchronologicaldecreaseintiterofneutralizingantibodyagainstsarscov2anditsvariantsofconcernsincovid19patients
AT takahashiyoshimasa immuneevasionandchronologicaldecreaseintiterofneutralizingantibodyagainstsarscov2anditsvariantsofconcernsincovid19patients
AT ishiimakoto immuneevasionandchronologicaldecreaseintiterofneutralizingantibodyagainstsarscov2anditsvariantsofconcernsincovid19patients
AT sayahideyuki immuneevasionandchronologicaldecreaseintiterofneutralizingantibodyagainstsarscov2anditsvariantsofconcernsincovid19patients
AT kondoyasushi immuneevasionandchronologicaldecreaseintiterofneutralizingantibodyagainstsarscov2anditsvariantsofconcernsincovid19patients
AT kanekoyuko immuneevasionandchronologicaldecreaseintiterofneutralizingantibodyagainstsarscov2anditsvariantsofconcernsincovid19patients
AT suzukikatsuya immuneevasionandchronologicaldecreaseintiterofneutralizingantibodyagainstsarscov2anditsvariantsofconcernsincovid19patients
AT fukunagakoichi immuneevasionandchronologicaldecreaseintiterofneutralizingantibodyagainstsarscov2anditsvariantsofconcernsincovid19patients
AT takeuchitsutomu immuneevasionandchronologicaldecreaseintiterofneutralizingantibodyagainstsarscov2anditsvariantsofconcernsincovid19patients
AT immuneevasionandchronologicaldecreaseintiterofneutralizingantibodyagainstsarscov2anditsvariantsofconcernsincovid19patients